C066-0424 Screening compound: N-(1,3-benzothiazol-2-yl)-2-{[3-(2,4-dimethoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

C066-0424 Screening compound: N-(1,3-benzothiazol-2-yl)-2-{[3-(2,4-dimethoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide
C066-0424 Screening compound: N-(1,3-benzothiazol-2-yl)-2-{[3-(2,4-dimethoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-0424
N-(1,3-benzothiazol-2-yl)-2-{[3-(2,4-dimethoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-0424

Molecular Formula

C26H21N5O5S (C26 H21 N5 O5 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-2-{[3-(2,4-dimethoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}acetamide

IUPAC name

N-(13-benzothiazol-2-yl)-2-{[3-(24-dimethoxyphenyl)-4-oxo-34-dihydrophthalazin-1-yl]formamido}acetamide

SMILES

COc(cc1)cc(OC)c1N1N=C(C(NCC(Nc2nc(cccc3)c3s2)=O)=O)c(cccc2)c2C1=O

InChI

InChI=1S/C26H21N5O5S/c1-35-15-11-12-19(20(13-15)36-2)31-25(34)17-8-4-3-7-16(17)23(30-31)24(33)27-14-22(32)29-26-28-18-9-5-6-10-21(18)37-26/h3-13H,14H2,1-2H3,(H,27,33)(H,28,29,32)

InChI Key

RFISIZSRDHKNDA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14714401

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

515.55

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.116

Distribution Coefficient, logD

4.116

Water Solubility, LogSw

-4.35

Polar Surface Area

98.245

Acid Dissociation Constant (pKa)

11.69

Base Dissociation Constant (pKb)

2.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.50

C066-0424 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C066-0424 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-0424?
Check Price and Availability of C066-0424, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-0424 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-0424
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-0424
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-0424 available by request